Gene · 6938
Papers1,800
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,800
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Systematic analysis of DNA methylation-mediated TF dysregulation on lncRNAs reveals critical roles in tumor immunity. | Mol Ther Nucleic Acids | 2023 | 38028194 | PubTator, text mining | PubMed |
| The Contribution of Mediastinal Transbronchial Nodal Cryobiopsy to Morpho-Histological and Molecular Diagnosis. | Diagnostics (Basel) | 2023 | 37998611 | PubTator, text mining | PubMed |
| Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023. | Obes Pillars | 2023 | 37990743 | PubTator, text mining | PubMed |
| γδ T cells: origin and fate, subsets, diseases and immunotherapy. | Signal Transduct Target Ther | 2023 | 37989744 | PubTator, text mining | PubMed |
| Advancing personalized medicine in brain cancer: exploring the role of mRNA vaccines. | J Transl Med | 2023 | 37978542 | PubTator, text mining | PubMed |
| In silico analysis of prognostic and diagnostic significance of target genes from prostate cancer cell lines derived exomicroRNAs. | Cancer Cell Int | 2023 | 37978493 | PubTator, text mining | PubMed |
| Joint multi-ancestry and admixed GWAS reveals the complex genetics behind human cranial vault shape. | Nat Commun | 2023 | 37973980 | PubTator, text mining | PubMed |
| Schnurri-3 drives tumor growth and invasion in cancer cells expressing interleukin-13 receptor alpha 2. | Cell Death Dis | 2023 | 37963919 | PubTator, text mining | PubMed |
| Bilateral intracochlear schwannomas: histopathological confirmation and outcomes following tumour removal and cochlear implantation with lateral wall electrodes. | HNO | 2023 | 37904024 | PubTator, text mining | PubMed |
| Hypoplastic Left Heart Syndrome: Signaling & Molecular Perspectives, and the Road Ahead. | Int J Mol Sci | 2023 | 37894928 | PubTator, text mining | PubMed |
| The Intergenic Type LncRNA (LINC RNA) Faces in Cancer with In Silico Scope and a Directed Lens to LINC00511: A Step toward ncRNA Precision. | Noncoding RNA | 2023 | 37888204 | PubTator, text mining | PubMed |
| Integrative genome-scale analyses reveal post-transcriptional signatures of early human small intestinal development in a directed differentiation organoid model. | BMC Genomics | 2023 | 37884859 | PubTator, text mining | PubMed |
| In silico engineering and simulation of RNA interferences nanoplatforms for osteoporosis treating and bone healing promoting. | Sci Rep | 2023 | 37875547 | PubTator, text mining | PubMed |
| Characterizing intergenic transcription at RNA polymerase II binding sites in normal and cancer tissues. | Cell Genom | 2023 | 37868033 | PubTator, text mining | PubMed |
| Pre-Operative Ocular Findings and Long-Term Follow-Up in a Large Cohort of Non-Syndromic Unicoronal Craniosynostosis. | J Clin Med | 2023 | 37834867 | PubTator, text mining | PubMed |
| Pan-cancer spatially resolved single-cell analysis reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment. | Mol Cancer | 2023 | 37833788 | PubTator, text mining | PubMed |
| CircUSP10 promotes liver cancer progression by regulating miR-211-5p/TCF12/EMT signaling pathway. | Heliyon | 2023 | 37829805 | PubTator, text mining | PubMed |
| End binding-3 inhibitor activates regenerative program in age-related macular degeneration. | Cell Rep Med | 2023 | 37794584 | PubTator, text mining | PubMed |
| TCF12 Activates TGFB2 Expression to Promote the Malignant Progression of Melanoma. | Cancers (Basel) | 2023 | 37760480 | PubTator, text mining | PubMed |
| ZFP64 Promotes Gallbladder Cancer Progression through Recruiting HDAC1 to Activate NOTCH1 Signaling Pathway. | Cancers (Basel) | 2023 | 37760477 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6938/papers?page=7